Not for human consumption, nor medical, veterinary, or household uses.
Peptide-based strategies, combined with smart delivery platforms and biomaterials, offer precise, stable, and targeted therapies for IBD, addressing key translational barriers
(Youre going to get blitzed, Koniver remembers Huberman saying.) On the podcast, Koniver said that almost everyone I could think of can benefit from peptides, and he highlighted an awesome, supersafe example called BPC-157
Despite the fact that the relationship between glucagon and body weight is well established, some research found no changes in food intake following glucagon administration, which suggests that appetite-independent mechanisms may play a role in the glucagon-mediated regulation of body weight [14]